Company intelligence / Profile preview

ELEHEAR

Shenzhen, Guangdong, Chinaelehear.com ↗

Ownership: Private
Development stage: Commercial

Overview

ELEHEAR Beyond and Elehear Beyond Pro are FDA-cleared over-the-counter hearing aids for mild to moderate hearing loss, offering AI-powered noise reduction, feedback cancellation, Bluetooth streaming, and optional tinnitus relief; devices are actively marketed and available for purchase as of September 2025[1][4][5].

Therapeutic areas: Neurology
Modalities: Device
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on ELEHEAR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ELEHEAR.

Explore the full profile